Assessing health facility performance in Indonesia using the Pabón-Lasso model and unit cost analysis of health services

The International Journal of Health Planning and Management
Firdaus HafidzSandy Tubeuf

Abstract

Total health care costs have dramatically increased in Indonesia, and health facilities consume the largest share of health resources. This study aims to provide a better understanding of the characteristics of the best-performing health facilities. We use 4 national Indonesian datasets for 2011 and analysed 200 hospitals and 95 health centres. We first apply the Pabón-Lasso model to assess the relative performance of health facilities in terms of bed occupancy rate and the number of admissions per bed; the model gathers together health facilities into 4 sectors representing different levels of productivity. We then use a step-down costing method to estimate the cost per outpatient visit, inpatient, and bed days in hospitals and health centres. We combined both ratio analysis and applied bivariate and multivariate analyses to identify the predictors of the best-performing health facility; 37% of hospitals and 33% of health centres were located in the high-performing sector of the Pabón-Lasso model. The wide variation in unit costs across health facilities presented a basis for benchmarking and identifying relatively efficient units. Combining the unit cost analysis and Pabón-Lasso model, we find that health facility performance...Continue Reading

References

Jun 9, 1986·The International Journal of Health Planning and Management·P Berman
Aug 30, 2000·Public Health·M El-ShazlyA Nicolucci
Feb 24, 2001·Healthcare Management Forum·C St-Hilaire, P K Crépeau
May 19, 2001·Health Policy and Planning·A GreenA Vassall
Dec 1, 2001·Health Services Management Research : an Official Journal of the Association of University Programs in Health Administration·B Helmig, I Lapsley
Jul 24, 2002·Health Policy and Planning·Cheryl E CashinOlga Zuess
Sep 11, 2002·Social Science & Medicine·Mike Smet
May 30, 2003·Cost Effectiveness and Resource Allocation : C/E·Taghreed AdamChristopher JL Murray
Feb 26, 2004·Health Policy and Planning·Lesong Conteh, Damian Walker
Apr 21, 2004·Medical Care Research and Review : MCRR·Mark W Smith, Paul G Barnett
Dec 6, 2008·The Journal of Continuing Education in the Health Professions·Eric S Holmboe
Jan 24, 2009·The International Journal of Health Planning and Management·Hoang Van MinhPamela Wright
Aug 25, 2009·Journal of Medical Systems·Keon-Hyung LeeMankyu Choi
Jun 12, 2010·Bulletin of the World Health Organization·Rob Yates
Aug 19, 2011·Journal of Health Organization and Management·Thuy Linh Pham
Nov 5, 2011·Asia Pacific Allergy·Constance H Katelaris
May 23, 2012·International Journal of Health Services : Planning, Administration, Evaluation·Ida Hellander, Rohith Bhargavan
Jan 1, 2011·The Australasian Medical Journal·Bahadori MohammadkarimNejati Mostafa
Aug 13, 2013·PloS One·Susmita ChatterjeeRamanan Laxminarayan
Mar 15, 2014·Biochemia Medica·Sandro Sperandei
Jul 8, 2014·Global Journal of Health Science·Mohammad MehrtakEbrahim Jaafaripooyan
Jan 1, 2014·International Journal for Equity in Health·Anna M Rodney, Peter S Hill

❮ Previous
Next ❯

Citations

Aug 3, 2020·Health Economics Review·Ahmed D AlatawiJahangir A M Khan
Mar 4, 2021·The International Journal of Health Planning and Management·Iyad Ibrahim ShaquraAli Akbari Sari
Nov 20, 2021·Inquiry : a Journal of Medical Care Organization, Provision and Financing·Asim MehmoodFahad Khan Azeez

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.